申请人:Shionogi&Co., Ltd.
公开号:EP2014285A1
公开(公告)日:2009-01-14
The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I):
wherein R1 is lower alkyl, cycloalkyl or the like,
R2 is hydrogen, lower alkyl or the like,
n is 1 or 2,
X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like,
Y is CONR7, CSNR7, NR7CO, NR7CS or the like,
Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like and R7 is hydrogen or lower alkyl,
prodrug, pharmaceutically acceptable salt or solvate thereof
本发明提供了一种用作 NPY Y5 受体拮抗剂的药物组合物,该组合物由式(I)化合物组成:
其中 R1 是低级烷基、环烷基或类似物、
R2 是氢、低级烷基或类似物、
n 是 1 或 2、
X 是低级烯烃、低级烯烃、芳基、环烷烃或类似物、
Y 是 CONR7、CSNR7、NR7CO、NR7CS 或类似物、
Z 是低级烷基、任选取代的碳环烷基、任选取代的杂环烷基或类似物,R7 是氢或低级烷基、
其原药、药学上可接受的盐或溶液